ALA 7.69% 18.0¢ arovella therapeutics limited

Offer from the Company, page-106

  1. 2,755 Posts.
    lightbulb Created with Sketch. 476
    Certainly seems that way was, Artimist had so much promise, has caused so many problems and yet to this day, has not helped one person... monumental bungle in my opinion. If that can’t be managed to a point of benefit, how can we be confident anything else will...
    Again, I’m not having a crack at management but rather, I’ve lost confidence in these products being compelling enough to sell themselves...
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.